Drug Companies Are Focusing on the Poor After Decades of Ignoring Them
Nearly 20 million Africans are now on H.I.V. treatment — for less than $100 a year. Top-quality drugs for malaria, tuberculosis, hepatitis C and some ...
|
View article...